In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BioScrip Inc.

Latest From BioScrip Inc.

The Quality Lowdown: Foreign Burden, Border Destruction, Particles, Sterility

FDA asks about regulating foreign firms more and destroying drugs at the border, and questions firms about particles and aseptic practices.

Manufacturing Quality

Mim: Taking a Generic Approach to PBM

Pharmacy benefit management has historically driven drug costs lower, at least in part by cutting dispensing fees and minimizing the pharmacist's role in managed care decision-making. But Mim is turning that around, using pharmacists' unique role in the dispensing episode to push higher-than-industry-norm levels of generic substitution.

BioPharmaceutical Regulation
See All

Company Information

  • Industry
  • Services
  • Therapeutic Areas
  • Alias(es)
  • MIM Corp.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • BioScrip Inc.
  • Senior Management
  • Richard (Rick) M Smith, CEO
    Hai V Tran, SVP, CFO
    Recie Bomar, VP, Sales & Mktg
    Todd R Palmieri, EVP, Bus. Dev.
  • Contact Info
  • BioScrip Inc.
    Phone: (914) 460-1600
    100 Clearbrook Rd.
    Elmsford, NY 10523